Forbes @Forbes
American pharmaceutical giant Pfizer announced a string of new deals Monday to expand and improve its use of mRNA technology, including a $1.3 billion partnership with gene editing company Beam Therapeutics. https://t.co/U5SbLZwRpu — PolitiTweet.org